Skip to main content

Table 1 Drug therapies administered in patients with hypertension and/or diabetes

From: Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

 

Total

DIA without HYP

DIA with HYP

HYP without DIA

Antihypertensive drugs (%)

47.21

 

100.00

58.19

Diuretics (%)

41.67

 

50.00

43.26

ACEi (%)

39.58

 

43.75

33.65

ARB (%)

34.03

 

40.00

35.58

β-blockers (%)

29.86

 

31.25

32.69

α-blockers (%)

5.56

 

7.50

2.88

Calcium antagonists (%)

18.06

 

23.75

18.27

Other antihypertensive drugs (%)

1.39

 

0.00

1.92

Antidiabetic drugs (%)

21.987

84.38

87.50

 

Insulin (%)

20.90

29.63

20.00

 

Metformin (%)

83.58

85.19

80.00

 

Sulfonylureas (%)

32.84

14.81

37.14

 

Meglitinides (%)

2.99

7.41

4.29

 

α-glucosidase inhibitors (%)

1.49

 

1.43

 

Glitazones (%)

  

7.14

 
  1. Data are expressed as percentages. ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; DIA, patients with diabetes; HYP, patients with hypertension.